Market Overview:
Global Next Generation Sequencing Market size and share is currently valued at USD 9.90 Billion in 2024 and is anticipated to generate an estimated revenue of USD 43.42 Billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 20.3% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032
Key Trends: Improvements in The Sequencing Technologies is Driving the Market Growth
Research Methodology:
Our research methodology combines qualitative and quantitative methods to offer a thorough analysis of the market. These research techniques used include:
- Focus Groups: Includes qualitative data and insights into customer attitudes and opinions.
- Surveys: Offers insights into consumer behavior, opinion, and interests.
- Interviews: The study covers in-depth conversations with individuals to collect information about attitudes, beliefs, and motivations.
- Secondary Research: The report analyzes existing data from reports, publications, and other credible sources.
All the information in the Next Generation Sequencing (NGS) market research report goes through a multi-step verification method to ensure its accuracy and reliability.
List of Market Key Players:
The market has the presence of both established players and new entrants. These players are focusing on innovation and strategic partnerships to expand their global reach and increase their Next Generation Sequencing (NGS) market share. Some of the key players in the market are:
- BGI
- Bio-Rad Laboratories, Inc.
- DNASTAR, Inc.
- Eurofins GATC Biotech GmbH
- Genomatix GmbH
- Illumina Inc.
- Invitae Corporation
- Oxford Nanopore Technologies
- Perkin Elmer, Inc.
- PierianDx
- Qiagen
- Roche Ltd.
- Thermo Fisher Scientific Inc.
Overview of Top Companies:
- BGI: BGI, originally known as the Beijing Genomics Institute, is a leading global genomics company based in Shenzhen, China. Established in 1999, BGI focuses on genomic research, bioinformatics, and biotechnology development.
- Bio-Rad Laboratories, Inc.: Bio-Rad Laboratories, Inc. is an American life sciences and clinical diagnostics company headquartered in Hercules, California, founded in 1952. Bio-Rad develops and manufactures products for laboratory research and diagnostics, including tools for molecular biology, immunoassays, and gene sequencing.
Browse More Information:
https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market
Competitive Landscape:
The competitive landscape of the market is shaped by strategic partnerships and collaborations among Next Generation Sequencing (NGS) market key players. These strategic initiatives are aimed at expanding their product portfolios and expanding their global reach. Companies like BGI, Bio-Rad Laboratories, Inc., DNASTAR, Inc., Eurofins GATC Biotech GmbH, Genomatix GmbH, Illumina Inc., Invitae Corporation, Oxford Nanopore Technologies, Perkin Elmer, Inc., PierianDx, Qiagen, Roche Ltd., Thermo Fisher Scientific Inc. are leveraging their global reach to cater to diverse consumer needs across various regions. Other players, such as BGI, Bio-Rad Laboratories, Inc., DNASTAR, Inc., are focusing on the incorporation of advanced technologies to improve their offerings. As the market evolves, the competition is set to intensify in the upcoming years.
Conclusion:
The Next Generation Sequencing (NGS) market growth is poised to continue in the upcoming years. Companies adapting to shifting consumer preferences and technological innovations will continue to thrive in the evolving market landscape.
More Trending Latest Reports By Polaris Market Research:
